Table 1. Patients’ Outcome After Salvage... | American Society of Hematology

Table 1.

Patients’ Outcome After Salvage Therapy

Patient No.	Duration of 1st Molecular Remission	PML/RARα PCR After Salvage Therapy			ABMT	Duration of 2nd Molecular Remission	Outcome
Patient No.	Duration of 1st Molecular Remission	Post-ATRA	Post-CHT	BM Harvest	ABMT	Duration of 2nd Molecular Remission	Outcome
1	11	Neg	Neg	Neg	Yes	22+	A & W in 2nd molecular remission
2	11	Pos	Neg	Neg	Yes	17+	A & W in 2nd molecular remission
3	12	Neg	Neg	Neg	Yes	16+	A & W in 2nd molecular remission
4	2	Neg	Neg	Neg	Yes	13	Hematologic relapse at 13 mo; 3rd molecular remission with ATRA/MTZ/AraC
5	11	Neg	Neg	ND	ND	11+	A & W in 2nd molecular remission
6	3	Neg	Neg	Neg	ND	10+	A & W in 2nd molecular remission
7	7	Pos	Neg	Neg	Yes	9+	A & W in 2nd molecular remission
8	9	Pos	Neg	ND	ND	8+	A & W in 2nd molecular remission
9	3	Neg	Neg	Neg	Yes	7+	A & W in 2nd molecular remission
10	4	Pos	Neg	Neg	Yes	6+	A & W in 2nd molecular remission
11	3	Neg	Neg	Neg	Yes	6	Hematologic relapse at 8 mo; patient is presently receiving As₂O₃ therapy
12	25	Pos	Neg	Neg	ND	4+	A & W in 2nd hematologic remission
13	2	Pos	Pos	ND	ND	—	Hematologic relapse at 10 mo; 2nd hematologic remission after As₂O₃
14	8	Pos	Pos	ND	ND	—	Hemorrhagic death in remission

Patient No.	Duration of 1st Molecular Remission	PML/RARα PCR After Salvage Therapy			ABMT	Duration of 2nd Molecular Remission	Outcome
Patient No.	Duration of 1st Molecular Remission	Post-ATRA	Post-CHT	BM Harvest	ABMT	Duration of 2nd Molecular Remission	Outcome
1	11	Neg	Neg	Neg	Yes	22+	A & W in 2nd molecular remission
2	11	Pos	Neg	Neg	Yes	17+	A & W in 2nd molecular remission
3	12	Neg	Neg	Neg	Yes	16+	A & W in 2nd molecular remission
4	2	Neg	Neg	Neg	Yes	13	Hematologic relapse at 13 mo; 3rd molecular remission with ATRA/MTZ/AraC
5	11	Neg	Neg	ND	ND	11+	A & W in 2nd molecular remission
6	3	Neg	Neg	Neg	ND	10+	A & W in 2nd molecular remission
7	7	Pos	Neg	Neg	Yes	9+	A & W in 2nd molecular remission
8	9	Pos	Neg	ND	ND	8+	A & W in 2nd molecular remission
9	3	Neg	Neg	Neg	Yes	7+	A & W in 2nd molecular remission
10	4	Pos	Neg	Neg	Yes	6+	A & W in 2nd molecular remission
11	3	Neg	Neg	Neg	Yes	6	Hematologic relapse at 8 mo; patient is presently receiving As₂O₃ therapy
12	25	Pos	Neg	Neg	ND	4+	A & W in 2nd hematologic remission
13	2	Pos	Pos	ND	ND	—	Hematologic relapse at 10 mo; 2nd hematologic remission after As₂O₃
14	8	Pos	Pos	ND	ND	—	Hemorrhagic death in remission

Abbreviations: ABMT, autologous bone marrow transplantation; ND, not done; A & W, alive and well; CHT, chemotherapy.